INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands |
3 Months Ended |
9 Months Ended |
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
| Cash flows from operating activities: |
|
|
|
|
| Net loss |
$ (5,336)
|
$ (4,488)
|
$ (18,267)
|
$ (19,996)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
| Depreciation |
67
|
56
|
190
|
155
|
| Stock-based compensation related to options granted to employees and directors |
196
|
1,017
|
726
|
2,198
|
| Change in operating lease liability |
8
|
(11)
|
(182)
|
(61)
|
| Decrease (increase) in other accounts receivable and prepaid expenses |
516
|
(1,095)
|
1,243
|
1,267
|
| Decrease in trade payables |
(261)
|
(1,321)
|
(2,678)
|
(11,394)
|
| Increase (decrease) in other accounts payable and accrued expenses |
(1,650)
|
(1,082)
|
(1,789)
|
216
|
| Total net cash used in operating activities |
(6,460)
|
(6,924)
|
(20,757)
|
(27,615)
|
| Cash flows from investing activities: |
|
|
|
|
| Purchase of property and equipment |
(237)
|
(88)
|
(295)
|
(145)
|
| Changes in short-term deposit |
1,933
|
2
|
1,915
|
(4,005)
|
| Total net cash provided by (used in) investing activities |
1,696
|
(86)
|
1,620
|
(4,150)
|
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from exercise of options |
|
20
|
5
|
52
|
| Proceeds from issuance of shares in at-the-market (ATM) offering (Note 7) |
(106)
|
13,307
|
6,998
|
39,690
|
| Proceeds from issuance of shares and warrants in Registered Direct Offering (Note 7) |
|
|
|
9,957
|
| Proceeds from exercise of warrants |
|
6,300
|
|
6,300
|
| Total net cash provided by (used in) financing activities |
(106)
|
19,627
|
7,003
|
55,999
|
| Increase (decrease) in cash and cash equivalents |
(4,870)
|
12,617
|
(12,134)
|
24,234
|
| Cash and cash equivalents at the beginning of the period |
30,565
|
12,153
|
37,829
|
536
|
| Cash and cash equivalents at end of the period |
$ 25,695
|
$ 24,770
|
$ 25,695
|
$ 24,770
|